Abstract
Background
Diagnosing sepsis remains a challenge because of the lack of gold-standard diagnostics. Since there are no simple, broadly accepted criteria for infection, there is a risk of misclassifying sepsis patients (sepsis mimics) among patients with organ failure. The main objective of this study was to investigate the proportion of non-infected patients (sepsis mimics) in ICU patients with presumed sepsis at intensive care unit (ICU) admission.
Methods
Adult patients were screened retrospectively during 3.5 years in four ICUs in Sweden for fulfilment of the sepsis-3 criteria at ICU admission (presumed sepsis). Proxy criteria for suspected infection were sampled blood culture(s) and concomitant antibiotic administration. Culture-negative presumed sepsis patients were screened for infection according to the Linder-Mellhammar Criteria of Infection (LMCI). Sepsis mimics were defined as without probable infection according to the LMCI. Confirmed sepsis was defined as presumed sepsis after the exclusion of sepsis mimics.
Results
In the ICU presumed sepsis cohort (2664 patients), 25% were considered sepsis mimics. The most common reasons for ICU admission among sepsis mimics were acute heart failure and unspecific respiratory failure. Comparing sepsis mimics and confirmed sepsis showed that confirmed sepsis patients were slightly more severely ill but had similar mortality. C-reactive protein had modest discriminatory power (AUROC 0.71) with confirmed sepsis as the outcome.
Conclusions
One-fourth of a presumed ICU sepsis population identified with the sepsis-3 criteria could be considered sepsis mimics. The high proportion of sepsis mimics has a potential dilutional effect on the presumed sepsis population, which threatens the validity of results from sepsis studies using recommended sepsis criteria.
Similar content being viewed by others
Explore related subjects
Find the latest articles, discoveries, and news in related topics.Avoid common mistakes on your manuscript.
Background
Sepsis is a frequent cause of Intensive Care Unit (ICU) admission, but criteria for sepsis identification vary between studies. The choice of criteria determines what cohorts are included and can affect treatment effects in intervention studies. [1, 2]. According to the sepsis-3 task force, the suggested clinical sepsis criteria are suspected or verified infection in combination with organ failure measured as an increase in Sequential Organ Failure Assessment (SOFA) score with two points or more [3]. Organ failure at ICU admission is common [4]. Therefore, the fulfilment of sepsis criteria will probably be determined by infection criteria fulfilment for a majority of the ICU patients.
There are no gold standard infection criteria, and the choice of infection criteria is probably the major cause for the difference in sepsis inclusion between studies. The sepsis-3 task force has suggested microbiological culture sampling in combination with antibiotic administration as criteria for suspected infection to be used for research purposes [3]. Physician suspicion of infection is another common approach [5, 6]. These proxy criteria for infection are easy to apply in large datasets and can be used in prospective studies. Other criteria for infection exist, such as the International Sepsis Forum definitions of infection in the ICU by Calandra et al. or the Center for Disease Control and Prevention (CDC) criteria[7, 8]. These criteria require a more in-depth assessment of clinical data, often rely on microbiological test results, and are consequently unsuitable for prospective studies. A new tool for diagnosing infection was published in 2022, the Linder-Mellhammar Criteria of Infection (LMCI). The aim was for a more comprehensive yet simple set of criteria to diagnose infection in 13 potential foci (compared to 6 in Calandra et al.). The LMCI classifies a patient as infected with four degrees of certainty: no, possible, probable or proven infection. The LMCI includes but does not rely on microbiological test results and is intended to be used in the ICU and hospital wards. A comparison with Calandra et al. showed higher agreement with expert adjudication for LMCI[9].
Broadly applicable criteria, such as culture sampling and antibiotic administration or clinical suspicion, risk including false positive patients, so-called sepsis mimics, in an ICU setting. This is because the threshold to suspect and treat an infection is low in critical illness. The issue of sepsis mimics was highlighted in the last version of the Surviving Sepsis Campaign [10]. The proportion of sepsis mimics has only been analysed in a few ICU studies, none using the sepsis-3 criteria, but all using physician suspicion of infection as a proxy criterion. Contou et al. investigated 508 patients with suspected infection needing vasopressor therapy at ICU admission and found that 11% were sepsis mimics [11]. Heffner et al. investigated 211 patients who were admitted to the ICU from the emergency department with sepsis-2 criteria for septic shock and found 16% to be sepsis mimics [12]. Klouwenberg et al. investigated 2579 patients who fulfilled sepsis-2-criteria at ICU admission and found that 13% had no infection [13].
Objectives
The objectives of this study were to investigate
-
The proportion of sepsis mimics among patients with presumed sepsis according to sepsis-3 criteria, including recommended proxy criteria for infection, at ICU admission
-
How these sepsis mimics differ from confirmed sepsis patients
-
The ability of frequently used clinical infection tools to discriminate between confirmed sepsis and sepsis mimics/non-sepsis
Methods
Study design
This study was a retrospective observational study with data collected mainly through electronic medical record (EMR) review. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines were followed[14].
Setting
Patients in this study were admitted to one of four general ICUs at Skåne University Hospital in Lund and Malmö, Helsingborg Hospital and Kristianstad Hospital, all located in the south of Sweden. The period of patient inclusion was from 2015 (different starting dates depending on site) until December 31, 2018. This period reflected the Swecrit biobank’s collection period, of which this study is an adjunct[15]. The study size was a convenience sample of all ICU admissions during a fixed period.
Participants
All adult ICU patients (\(\ge\)18 years old) were retrospectively screened for the fulfilment of sepsis-3 criteria around the time of ICU admission (see previous publication for details [16]). Sepsis was defined as SOFA-score\(\ge\)2 within the time frame 1 h before to 1 h after ICU admission in combination with suspected infection. Proxy criteria for suspected infection were blood cultures sampled within 24 h before to 24 h after ICU admission, and \(\ge\)1 dose of antibiotic therapy administered, according to recommendations of the sepsis-3 task force [3]. The exclusion criteria were direct transfer from another ICU or elective ICU admission after surgery. All patients included in the analyses are termed presumed sepsis.
Culture-negative presumed sepsis patients were screened for infection using the LMCI[9]. The cutoff for infection was chosen at 3 points or more within at least one focus of infection (probable or proven infection) or fulfilment of criteria for possible or definite endocarditis according to the modified Duke criteria[17]. Failure to reach this cutoff within any focus led to the classification of a sepsis mimic. The remaining sepsis patients, after the exclusion of sepsis mimics, were called confirmed sepsis. Sepsis mimics were used as a reference group to confirmed sepsis. In summary, this study’s gold standard for infection was culture positivity, or probable infection, according to LMCI for culture-negative patients.
Data sources
The LMCI review of EMR was performed by three research group members, two intensive care residents and one intensive care attending. Uncertainties were discussed with co-author LM, who is an infectious medicine specialist. A review of the comorbidities in the EMR was performed by a group of trained data collectors, mainly intensive care residents and medical students.
Survival data, diagnostic coding, Simplified Acute Physiology Score-3 (SAPS-3) and SOFA scores, vital signs and variables used to calculate SAPS-3 and SOFA were based on data entered by the treating physician into the PasIVA software, used to collect data for the Swedish Intensive Care Registry (SIR). Laboratory values and microbiological test results were automatically extracted from the hospital laboratory electronic system. See Supplement 3 for the data sources of variables used in Table 1.
Variables
Culture-negative presumed sepsis was defined as without clinically relevant pathogen detected in any sample within 48 h before to 48 h after ICU admission. See Supplement 1 for the definition of clinically relevant culture results.
Sepsis mimics were assessed for retrospective causes of ICU admission to identify what diagnoses constitute sepsis mimics in the ICU. All medical information available at the EMR review was considered, including relevant medical investigations performed after ICU admission and autopsies. The diagnoses were applied in an inductive manner, where the medical state assessed to have primarily contributed to ICU admission was chosen as a diagnosis at ICU admission. Diagnoses were aggregated into diagnostic categories to facilitate reporting. A combined pie/doughnut chart was constructed based on the diagnostic categories, with diagnoses <1.5% of the sepsis mimics subgroup not being labelled. All levels of diagnoses/categories, descriptions of all diagnoses and frequency counts were reported separately in Supplement 2. Two mock patient case reports were constructed based on an aggregation of multiple patients and with details distorted to ensure patient confidentiality.
A physician’s suspicion of infection was defined as an explicit suspicion of infection or sepsis by any physician during ICU admission, as stated in the EMR.
Shock was defined as using vasopressor (norepinephrine or epinephrine) at ICU admission, combined with a lactate level of >2 mmol/L.
Sepsis diagnosis was defined as ICD-10 codes R57.2, R65.1, and A41.9 as a main or secondary diagnosis at ICU discharge.
Quantitative variables
For the biomarkers C-reactive protein (CRP), procalcitonin (PCT), white blood cell count (WBC) and lactate, the highest values within the time frame 48 h before to 48 h after ICU admission were identified. The biomarkers that were used in diagnostic testing were dichotomised according to receiver operating characteristics curve (ROC)-derived optimal cutoffs (Youden’s index)[18].
Body temperature was the highest recorded within 1 h before to 1 h after ICU admission. Fever was defined as temperature \(> 38^{\circ } \hbox {C}\) and hypothermia as \(< 36^{\circ } \hbox {C}\).
See Supplement 3 for an exhaustive list of variable definitions and data sources for Table 1.
Statistical methods
All data handling procedures and statistical analyses were performed using RStudio. Median values and interquartile ranges (IQRs) were reported for continuous variables. Despite SOFA scores being an ordinal variable, mean value and standard deviation (SD) were reported for SOFA scores since we believed this better illustrated the distribution than a presentation of frequencies of all SOFA-score levels.
To assess for a difference in the location of two independent variables, the Wilcoxon rank-sum test (Mann–Whitney U test) was used. Differences in proportions were assessed using Pearson’s \(\chi ^2\) test. For all hypotheses testing, p-values <0.05 were considered significant.
Commonly used variables in the clinical setting (CRP, PCT, WBC and body temperature) were assessed in ROC analyses and diagnostic testing, with dichotomised variables and values above the cutoff considered a positive test to identify confirmed sepsis (positive outcome).
If data were missing in hypothesis testing, ROC analyses or diagnostic testing, the patient was excluded from analyses using that specific variable.
Four sensitivity analyses were performed. We assessed the change in the proportion of sepsis mimics when only patients (1) fulfilling shock criteria were included and (2) with \(\ge\)4 days of antibiotic therapy among patients with available data on antibiotic therapy. Additional sensitivity analyses were performed with (3) stricter criteria and (4) more liberal criteria for infection according to LMCI:
(3) The cutoff was elevated to \(\ge\)4 points (proven infection) for any focus. The modified Duke criteria were changed to only include definite endocarditis. (4) The cutoff was lowered to \(\ge\)2 points (possible infection) for any focus, except for the gastrointestinal (GI) focus, since leukocytosis or fever is enough to give 2 points there. The modified Duke criteria for endocarditis were not changed.
See Supplement 1 for details on the method for sensitivity analysis two.
Bias
The LMCI has some subjectivity (e.g. interpretation of radiological results). To minimise differences in assessment between the data collectors, uncertainties were discussed and jointly agreed on between the three investigators and the infectious disease specialist.
Results
Participants
Of 8360 ICU admissions during the study period, 2664 (32%) fulfilled the operational sepsis-3 criteria after exclusion criteria and were labelled presumed sepsis. Of these, 1122 were culture-negative and subject to review according to the LMCI. See flow chart Fig. 1.
Main results
Proportion of sepsis mimics
Out of the 2664 ICU patients with presumed sepsis, 656 (25%, 95% confidence interval 23–26%) were culture negative and did not fulfil criteria for probable infection according to the LMCI and were thus labelled sepsis mimics.
Sepsis mimics diagnoses
Most sepsis mimics had cardiovascular or respiratory diagnoses as causes for ICU admissions, such as unspecific respiratory failure, acute heart failure or cardiac arrest. See Fig. 2 for an illustration of the diagnoses in sepsis mimics. See Supplement 2 for definitions of diagnoses and diagnostic categories in sepsis mimics and frequency counts. Two illustrative patient cases from the most common categories are presented in text box 1.
Differences between sepsis mimics and confirmed sepsis
The sepsis mimics subgroup differed in some aspects from the confirmed sepsis population (see Table 1). In sepsis mimics, the bedside physicians had less suspicion of infection (70% vs 87%, p<0.05). There was no difference in hospital length of stay before ICU admission. The disease severity was higher in the confirmed sepsis group, as measured with the SAPS-3 and SOFA scores. The confirmed sepsis group had a higher need for vasopressors, but lactate levels were similar. The confirmed sepsis group had a higher degree of respiratory failure according to the oxygenation index (PF-ratio), as well as the subsequent need for invasive ventilation. Among the different organ-specific SOFA scores, only the neurological score was higher in sepsis mimics. The other organ-specific SOFA scores were higher in confirmed sepsis. The proportion with pre-ICU comorbidities only differed regarding immunosuppression (more common in the confirmed sepsis group) and cardiovascular and respiratory disease (more common in the mimics group), although the differences were small.
Biomarker and body temperature differences
Among the biomarkers, CRP and PCT values were markedly lower in sepsis mimics than in the confirmed sepsis group. The absolute difference was small in WBC between sepsis mimics and confirmed sepsis. Fever was more common in the confirmed sepsis group, and hypothermia was less common. See Fig. 4.
Outcome data
Despite the sepsis mimics group being less severely ill at ICU admission, the crude mortality did not differ between the mimics and confirmed sepsis. The ICU and hospital stay was longer, and the need for continuous renal replacement therapy (CRRT) and invasive ventilation during the ICU stay was higher in the confirmed sepsis group. See Table 1.
Other analyses
ROC analysis and diagnostic testing of biomarkers and body temperature
The ability of CRP, PCT, WBC and body temperature to discriminate between sepsis mimics and confirmed sepsis was tested using ROC analysis. CRP and PCT had AUCs around 0.7, but WBC and temperature had low discriminatory capabilities, with AUCs closer to 0.5.
High values of dichotomised CRP, PCT, WBC and temperature (positive test) were tested against confirmed sepsis (positive outcome) among presumed sepsis patients. Discriminatory capabilities were modest for all four tests, with CRP, WBC and temperature yielding specificities around 80% but with sensitivities between 25–51%. Positive predictive values (PPV) were high for all four tests, owing to the high prevalence of the outcome (confirmed sepsis) in the presumed sepsis group. See Table 2.
ROC analyses and diagnostic testing were also performed in the whole ICU population (see Table S1 in Supplement 1), with confirmed sepsis (n=2008) still being the positive outcome, but the reference group being all non-sepsis (including sepsis mimics), n=6352. AUCs improved for all four tests, with lower optimal cutoffs for CRP and WBC. The dichotomised tests yielded sensitivities and specificities that were more similar (between 47–70%), except for temperature, which had much higher specificity (91%) than sensitivity (25%).
Sensitivity analyses - proportion sepsis mimics with altered criteria for sepsis and mimics
Sensitivity analyses were performed to assess the proportion of sepsis mimics by altering the criteria for presumed sepsis and sepsis mimics. See Fig. 5.
If only presumed sepsis patients with shock (vasopressor and lactate>2) were included, the proportion of sepsis mimics fell to 21%. The pattern of diagnoses would also be different if only patients with shock were included, as illustrated in Fig. 3.
Changing the proxy criteria for infection to only include patients with \(\ge\)4 days of antibiotic treatment, the number with presumed sepsis was reduced, and the proportion of sepsis mimics was 20% (see Figure 1 in Supplement 1).
Using other cutoffs for LMCI, the proportion of sepsis mimics was 29% with the stricter infection criteria (\(\ge\)4 LMCI points, proven infection) and 14% with the more liberal infection criteria (\(\ge\)2 LMCI points, at least possible infection).
The change in the proportion of sepsis mimics was statistically significant (p-value<0.05) for all sensitivity analyses (see Table S2 in Supplement 1).
Discussion
Key results
In this retrospective observational study, we found that 25% of the patients with presumed sepsis at ICU admission did not fulfil more accurate infection criteria and could, therefore, be considered sepsis mimics. CRP, PCT, WBC and temperature were found to have low to moderate discriminatory power in distinguishing confirmed sepsis from sepsis mimics.
The sepsis mimics group was heterogeneous, with many non-infectious reasons for ICU admission. However, infection was initially suspected in most sepsis mimics (70%), reflecting the low threshold of suspecting infection in ICU patients. Most had non-infectious circulatory or respiratory causes for ICU admission, such as acute heart failure or mixed or unspecified respiratory failure. A small proportion (6%) of the sepsis mimics found using the LCMI criteria were considered to have sepsis in a clinical review. Of these sepsis mimics, most had sepsis of other/mixed origin or respiratory tract infection. The reason for them not fulfilling the LMCI criteria for probable infection could be a rapid clinical course not allowing for radiology to be performed or a respiratory tract infection not presenting with infectious infiltrate on radiology. This illustrates the discrepancy between what is clinically considered sepsis and the criteria used for research.
The confirmed sepsis group had a higher degree of shock due to a higher proportion of vasopressor need, as the lactate levels were similar. In sepsis mimics, lactatemia was probably caused by reasons other than sustained hypoperfusion.
Compared to previous ICU studies of sepsis mimics using physician suspicion of infection as proxy criteria for infection, we found almost twice the proportion of sepsis mimics (11–18% vs 25%) [11,12,13]. This is partly due to our study including all patients with presumed sepsis instead of only including presumed septic shock patients, highlighted by the slight decrease in sepsis mimics to 21% if only presumed shock patients were included. This fraction is still higher than found in previous studies, probably due to the choice of infection proxy criteria, with blood culture sampling and antibiotic therapy yielding more sepsis mimics than physician suspicion in an ICU setting. The cutoff for infection and choice of infection classification tool also matters: if Klouwenberg et al. had set their infection cutoff to probable or proven infection (not possible), their proportion of sepsis mimics would have been 43% instead of 13%. Our sensitivity analysis also illustrated this, which yielded highly variable proportions of sepsis mimics depending on the LMCI cutoff. Klouwenberg et al. used Calandra and CDC infection criteria, which only have a 66% overlap with the LMCI in ICU patients, which complicates comparisons[7,8,9]. The diagnoses that constitute sepsis mimics differed as well, with our most frequent mimic categories not being found in Contou et al., who instead reported adverse drug reactions, vascular disease and malignancies as the most frequent mimic categories. Only including shock patients changed our diagnoses, omitting a majority of the sepsis mimics with respiratory failure.
Using diagnostic coding to identify sepsis will also include possible sepsis mimics, as 14% of our cohort’s sepsis mimics had an ICD-10 sepsis diagnosis registered. Diagnostic coding will also underestimate criteria-based sepsis, leaving diagnostic coding unsuitable for sepsis identification[16].
The variation in sepsis inclusion, depending on slight changes in criteria, illustrates the methodological difficulty in sepsis research, and there is no clear answer to which infection proxy criteria should be used for criteria-based sepsis research. Noteworthy, however, is that all our sensitivity analyses yielded a high and non-negligible proportion of sepsis mimics. Different criteria will probably be suitable depending on the study design, but using only a limited selection of clearly defined criteria will facilitate generalisability and comparison between studies. Prospective studies cannot rely on microbiological test results, which are present after a few days. Still, more detailed clinical criteria (such as the LMCI, including microbiological test results) can be used for retrospective sensitivity analyses of prospective studies to assess the robustness of the results.
Large datasets derived from registries will probably have to rely on simple proxy criteria for infection. Still, the high risk of sepsis mimics inclusion needs to be considered. The trend towards using big data and machine learning algorithms makes the issue of sepsis mimics highly important. However, emerging methods to automatically collect clinical data from EMR could lead to more simplified screening of complex infection classification tools, hopefully improving sepsis identification.
The investigation of CRP, PCT, WBC and body temperature for diagnostic purposes with sepsis mimics as the control group has relevance to the research methodology. None of these clinical markers has high enough discriminatory power to be used in adjunct to the simple infection proxy criteria to identify sepsis according to more detailed criteria (LMCI) and single out sepsis mimics. The +LR of WBC close to 1 means that the test adds little to the assessment of sepsis, which is in line with previous research concluding the uselessness of WBC in sepsis[19]. An ideal marker as an adjunct to infection proxy criteria would have a high specificity to minimise the inclusion of sepsis mimics, which was the case for CRP, WBC and temperature. The low sensitivity would, however, leave many with confirmed sepsis to not be included in a final cohort.
These markers also have potential clinical relevance. The ability to discriminate between confirmed sepsis and all non-sepsis in the ICU was modest. CRP and PCT had better discriminatory power than WBC and temperature. Neither had a high sensitivity to be acceptable as decision support to withhold antibiotics, which is well established[20]. The optimal cutoff for CRP, 124 mg/L, was above the range of previously suggested cutoffs of 12–90 mg/L ([21]. Conclusions regarding PCT are difficult to draw because of the large proportion of missing PCT values and the high likelihood of selection bias in PCT differences in our study.
Limitations
In this study, screening for the fulfilment of LMCI and physician suspicion of infection was not performed on the entire ICU population. There might be patients with SOFA\(\ge\) 2 who fulfilled infection criteria according to LMCI at admission but did not have blood cultures sampled and were not included as presumed sepsis. If the LMCI were screened in the whole ICU population, it would have been possible to test the ability of the infection proxy criteria (blood culture sampling and antibiotic treatment) and the physician’s suspicion of infection as a test to identify sepsis correctly with LMCI as the gold standard for infection/sepsis.
Infection criteria tools, such as LMCI, have limitations since radiology, microbiological samples and other clinical workups are not performed in every patient due to low suspicion of positive findings or rapid clinical deterioration of the patient, which could be a source of selection bias. Since more severely ill patients are probably more thoroughly investigated, the proportion of confirmed sepsis could be higher among the more severely ill, contributing to the differences in SAPS-3 and SOFA scores between confirmed sepsis and sepsis mimics.
We did not investigate interobserver variability between investigators. We can, therefore, not rule out that the results would have differed slightly if the review of all cases was done independently by all three investigators and a result was jointly agreed on. In the original publication of the LMCI, an interobserver agreement of 77% was reported, and if looking at only those re-classified from non-infected to infected, that proportion was 12%.
The high proportion of missing PCT values is probably due to selection bias since PCT was not tested routinely in the included ICUs at the time of the study. Physicians ordered PCT on clinical indication, and the proportion of available PCT was higher in the confirmed sepsis group, i.e. not missing at random.
We analysed only single biomarker values in this study. If biomarker trajectories had been analysed instead, these biomarkers could have better clinical performance [20].
The effort of trying to categorise patients with critical illness into clinical syndromes, such as sepsis, is under investigation since the heterogeneity in pathophysiology is not taken into account [22]. The current sepsis criteria might become obsolete in the near future, but as long as they are in use, their weaknesses must be evaluated.
Interpretation
The poor ability of frequently used clinical tests to identify confirmed sepsis in a presumed sepsis cohort prompts the need for more precise biomarkers or combinations of biomarkers for diagnostic purposes.
The LMCI criteria are labour-intensive, and a future research topic could be to find simpler proxy criteria that can identify infection and sepsis more precisely.
Generalisability
The high proportion of sepsis mimics among presumed sepsis in our study has relevance as studies using the same criteria for presumed sepsis in an ICU setting similar to ours can expect a similarly high proportion of sepsis mimics. Using the infection proxy criteria of blood culture sampling and antibiotic administration can also be a source of selection bias, especially between ICU and non-ICU settings since the threshold to obtain blood cultures and administer antibiotics probably is lower in critically ill ICU patients. Using this infection proxy criterion can at first glance seem like an objective criterion, but the threshold to obtain blood cultures and administer antibiotics can be highly variable between physicians, wards and hospitals.
Conclusions
One-fourth of a presumed sepsis population identified with the sepsis-3 criteria could be considered sepsis mimics. The ability of frequently used clinical markers of infection to improve sepsis identification was low to modest. The high proportion of sepsis mimics has a potential dilutional effect on the presumed sepsis population, which threatens the validity of results from sepsis studies using recommended sepsis criteria.
Availability of data and materials
The datasets generated and analysed during the current study are not publicly available due to limitations in the ethical approval of the study and data management policies of Region Skåne. Still, they are available from the corresponding author on request.
Code availability
Available from the corresponding author on request.
Abbreviations
- AMI:
-
Acute myocardial infarction
- AUROC:
-
Area under receiver operating curve
- CA:
-
Cardiac arrest
- CDC:
-
Center for disease control and prevention
- COPD:
-
Chronic obstructive pulmonary disorder
- CRP:
-
C-reactive protein
- CRRT:
-
Continuous renal replacement therapy
- CT:
-
Computer tomography
- EMR:
-
Electronic medical record
- HT:
-
Hypertensive
- ICD-10:
-
International statistical classification of diseases and related health problems version 10
- ICH:
-
Intracranial haemorrhage
- ICU:
-
Intensive care unit
- IQR:
-
Interquartile range
- LMCI:
-
The Linder-Mellhammar criteria of infection
- LOS:
-
Lenght of stay
- LR:
-
Likelihood ratio (+; positive, -; negative)
- PF-ratio:
-
PaO2/FiO2 (oxygenation index)
- PCT:
-
Procalcitonin
- ROC:
-
Receiver operating characteristics curve
- SAPS-3:
-
Simplified acute physiology score 3
- SD:
-
Standard deviation
- SIR:
-
Swedish intensive care registry
- SOFA:
-
Sequential organ failure assessment
- STROBE:
-
Strengthening the reporting of observational studies in epidemiology
- WBC:
-
White blood cell count
References
Rhee C, Klompas M. Sepsis trends: increasing incidence and decreasing mortality, or changing denominator? J Thorac Dis. 2020;12(Suppl 1):S89.
Cavaillon JM, Singer M, Skirecki T. Sepsis therapies: learning from 30 years of failure of translational research to propose new leads. EMBO Mol Med. 2020;12(4): e10128.
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801–10.
Vincent JL, Marshall JC, Namendys-Silva SA, François B, Martin-Loeches I, Lipman J, et al. Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit. Lancet Respir Med. 2014;2(5):380–6.
Shankar-Hari M, Harrison D, Rubenfeld G, Rowan K. Epidemiology of sepsis and septic shock in critical care units: comparison between sepsis-2 and sepsis-3 populations using a national critical care database. Br J Anaesth. 2017;119(4):626–36.
Szakmany T, Pugh R, Kopczynska M, Lundin RM, Sharif B, Morgan P, et al. Defining sepsis on the wards: results of a multi-centre point-prevalence study comparing two sepsis definitions. Anaesthesia. 2018;73(2):195–204.
Calandra T, Cohen J, et al. The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med. 2005;33(7):1538–48.
Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309–32.
Mellhammar L, Elén S, Ehrhard S, Bouma H, Ninck L, Muntjewerff E, et al. New, useful criteria for assessing the evidence of infection in sepsis research. Crit Care Explor. 2022;4(5): e0697.
Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181–247.
Contou D, Roux D, Jochmans S, Coudroy R, Guérot E, Grimaldi D, et al. Septic shock with no diagnosis at 24 hours: a pragmatic multicenter prospective cohort study. Crit Care. 2016;20(1):1–10.
Heffner AC, Horton JM, Marchick MR, Jones AE. Etiology of illness in patients with severe sepsis admitted to the hospital from the emergency department. Clin Infect Dis. 2010;50(6):814–20.
Klein Klouwenberg P, Cremer OL, van Vught LA, Ong DS, Frencken JF, Schultz MJ, et al. Likelihood of infection in patients with presumed sepsis at the time of intensive care unit admission: a cohort study. Crit Care. 2015;19(1):1–8.
Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147(8):573–7.
Friberg H. Swecrit Biobank - Blood Samples From Critically Ill Patients and Healthy Controls (SWECRIT); 2021. ClinicalTrials.gov.
Lengquist M, Lundberg OHM, Spångfors M, Annborn M, Levin H, Friberg H, et al. Sepsis is underreported in Swedish intensive care units: a retrospective observational multicentre study. Acta Anaesthesiol Scand. 2020;64(8):1167–76.
Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30(4):633–8.
Berrar D. Performance measures for binary classification. In: Ranganathan S, Gribskov M, Nakai K, Schönbach C, editors. Encyclopedia of bioinformatics and computational biology. Oxford Academic Press: Oxford; 2019. p. 546–60.
Farkas JD. The complete blood count to diagnose septic shock. J Thorac Dis. 2020;12(Suppl 1):S16.
Póvoa P, Coelho L, Dal-Pizzol F, Ferrer R, Huttner A, Conway Morris A, et al. How to use biomarkers of infection or sepsis at the bedside: guide to clinicians. Intensive Care Medicine. 2023; 1–12.
Tan M, Lu Y, Jiang H, Zhang L. The diagnostic accuracy of procalcitonin and C-reactive protein for sepsis: a systematic review and meta-analysis. J Cell Biochem. 2019;120(4):5852–9.
Maslove DM, Tang B, Shankar-Hari M, Lawler PR, Angus DC, Baillie JK, et al. Redefining critical illness. Nat Med. 2022;28(6):1141–8.
Acknowledgements
The authors would like to thank all collaborators in the SepCrit and Swecrit projects who have contributed to data collection. A special thanks to medical illustrator Mattias Karlén, who created the graphical abstract and contributed to the figures in the manuscript.
Funding
Open access funding provided by Lund University. Lund University provided Open Access funding. ML: regional research support, Region Skåne #2021–0907. AF: Regional research support, Region Skåne #2022–1284; Governmental funding of clinical research within the Swedish National Health Service (ALF) #2022:YF0009 and #2022–0075; Crafoord Foundation grant number #2021–0833; Lions Skåne research grants; Skåne University Hospital grants; Swedish Heart and Lund Foundation (HLF) #2022–0352 and #2022–0458. LM: Governmental funding of clinical research within the Swedish National Health Service (ALF). The funding organisations had no role in the design and execution of the study (collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and the decision to submit the manuscript for publication).
Author information
Authors and Affiliations
Contributions
ML and LM designed the study. ML, AV and SA collected data through a review of medical records. ML and AV performed statistical analyses and prepared the figures. ML, AF and LM wrote the draft manuscript. All authors read, provided critical revisions, and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Ethical approval
The study protocol was approved by the Regional Ethical Review Board of Lund, Sweden (registration no. 2017/802, approved November 9, 2017) and was performed in accordance with the 1964 Declaration of Helsinki.
Consent to participate
Not applicable.
Consent for publication
Not applicable.
Supplementary Information
Below is the link to the electronic supplementary material.
Supplementary file2 Supplement 2 - diagnoses and diagnostic categories in sepsis mimics.(XLSX 23 kb)
15010_2023_2158_MOESM3_ESM.xlsx
Supplementary file3 Supplement 3 - variable list, data sources and proportions missing for variables in Table 1.(XLSX 13 kb)
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Lengquist, M., Varadarajan, A., Alestam, S. et al. Sepsis mimics among presumed sepsis patients at intensive care admission: a retrospective observational study. Infection 52, 1041–1053 (2024). https://doi.org/10.1007/s15010-023-02158-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15010-023-02158-w